BIOMAT Database Logo BIOMAT Database Logo

High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease. 1994

P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
Department of Haematology, University Hospital Dijkzigt, Rotterdam, The Netherlands.

Patients with acquired von Willebrand disease may present with severe bleeding, which is usually difficult to manage. Adequate haemostasis in acquired von Willebrand disease may be achieved with the infusion of factor VIII/von Willebrand factor concentrates or with the administration of desmopressin. We report a case of acquired von Willebrand disease with severe postoperative bleeding, responding poorly to classical von Willebrand factor replacement therapy but successfully treated with high-dose intravenous gammaglobulins. This new treatment mode of acquired von Willebrand disease is discussed in the light of a critical analysis of the literature.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins
D006488 Hemostasis, Surgical Control of bleeding during or after surgery. Surgical Hemostasis,Hemostases, Surgical,Surgical Hemostases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014842 von Willebrand Diseases Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. Angiohemophilia,Hemophilia, Vascular,von Willebrand Disease,Vascular Pseudohemophilia,Von Willebrand Disorder,Von Willebrand's Factor Deficiency,von Willebrand Disease, Recessive Form,von Willebrand's Disease,von Willebrand's Diseases,Angiohemophilias,Disorder, Von Willebrand,Pseudohemophilia, Vascular,Pseudohemophilias, Vascular,Vascular Hemophilia,Vascular Hemophilias,Vascular Pseudohemophilias

Related Publications

P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
Intravenous gammaglobulin therapy for acquired von Willebrand disease.
April 1998, European journal of haematology,
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
High-dose intravenous gammaglobulin for acquired von Willebrand's disease.
November 1988, British journal of haematology,
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease.
May 1995, Thrombosis and haemostasis,
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
Acquired von Willebrand disease: correction of hemostatic defect by high-dose intravenous immunoglobulins.
June 1992, American journal of hematology,
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
Acquired von Willebrand disease in monoclonal gammapathies: effectiveness of high-dose intravenous gamma globulin.
July 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis,
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
High-dose intravenous gammaglobulin therapy for uveitis.
January 1989, Metabolic, pediatric, and systemic ophthalmology (New York, N.Y. : 1985),
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
High-dose intravenous gammaglobulin for Kawasaki disease.
November 1984, Lancet (London, England),
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
High-dose intravenous gammaglobulin for Kawasaki disease.
December 1983, Lancet (London, England),
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery.
September 1992, British journal of haematology,
P J Van Genderen, and D N Papatsonis, and J J Michiels, and J J Wielenga, and J Stibbe, and F J Huikeshoven
The use of high-dose intravenous gamma-globulin in acquired von Willebrand syndrome.
February 1988, Archives of pathology & laboratory medicine,
Copied contents to your clipboard!